Detalhe da pesquisa
1.
IL-6-based mortality risk model for hospitalized patients with COVID-19.
J Allergy Clin Immunol;
146(4): 799-807.e9, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32710975
2.
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.
Sci Transl Med;
16(734): eadg7962, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38354229
3.
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.
Oncoimmunology;
12(1): 2205336, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37114242
4.
Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies.
Oncoimmunology;
11(1): 2054106, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35355682
5.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Cancer Immunol Res;
10(4): 498-511, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35362043
6.
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity.
Clin Cancer Res;
27(11): 3167-3177, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33785484
7.
Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies.
Front Immunol;
11: 1792, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32903593